|
|
| |
| |
 |
Patient
Confidentiality |
|
| |
Do you know who was here
this morning?" the
pharmacist phoned his
wife" Your cousin, Hessa.
I filled a prescription
for her for *Puregon®. I
just figured out why
they do not have
children yet after 5
years of marriage.
The Bridge Comment:
Pharmaceutical care
practitioners deal with
patient- specific
information that is
personal and sensitive,
therefore patient
confidentiality and
privacy must be
maintained at all times.
This includes all
written documents and
records, as well as
verbal discussions,
which must be held in
the strictest of
confidence.
Patients trust
practitioners, they are
expecting their personal
information to be
restricted to those
directly involved in
their care. This
includes the prohibition
of practitioners from
discussing individual
patient cases with
friends, family members,
or any other clinicians
or lay individual
without the informed
consent of the patient.
It would be considered
unethical to discuss or
disclose personal
health- related
information about your
patient with one of your
friends or family
members who is not
health care provider and
who is not involved in
the care of the patient
(1).
Being proficient and
knowledgeable in one's
field is not enough. The
practitioner should be
considerate and
compassionate, and
should maintain absolute
confidentiality of the
person(s) or family
involved. The Prophet
Mohammed (r) said:
"Whoever guards the
secrets of a Muslim, God
will guard their secret
in this life and on
resurrection day"
(narrated by Muslim)
(2).
In health care practice
confidentiality is not
an absolute, it has two
exceptions, this will be
tackled soon in The
Bridge, be with us at
that time.
*Puregon®: recombinant
follicle-stimulating
hormone (FSH).
Puregon® is indicated for the treatment of female infertility
in the following clinical situations
• Anovulation (including
polycystic ovarian
disease, PCOD) in
women who have been unresponsive to treatment with
clomiphene citrate.
• Controlled ovarian (hyper)stimulation
to induce the
development of multiple follicles in medically assisted
reproduction programs [e.g. in vitro fertilization / embryo
transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and
intracytoplasmic sperm injection (ICSI)].
Manal Zaidan, BSc (Pharm),
Clinical Pharmacist,
Al-Amal Cancer Center-
Hamad Medical
Corporation. Doha,
Qatar.
|
 |
|
|